Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zinc oxide + white soft paraffin is a topical combination medication used primarily as a skin protectant and emollient. Manufactured by NI-THE Pharmaceuticals, this formulation combines the properties of zinc oxide—a mild astringent and antiseptic that provides a physical barrier against irritants—with white soft paraffin (also known as petrolatum), which acts as an occlusive emollient. By forming a protective layer on the skin, it prevents transepidermal water loss and shields the skin from external moisture and friction, making it effective for treating conditions such as diaper rash, minor burns, and various forms of dermatitis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on zinc oxide + white soft paraffin.